Recently, with the analysis of human circulating interleukins and confirmation by an animal model, Monteiro et al. reported a differential inflammasome activation predisposing to compensated LC (IL-1α dominance) and re-compensated AD/ACLF (IL-1β dominance) [12]. This evidence concerns the gene IL1B and Alzheimer disease.